SA CORONA VIRUS WEBSITE

COVID-19 | SUBSCRIBE | FAQs

GENERAL, ECTD & HUMAN MEDICINES COMMUNICATION TO INDUSTRY

Document Number	Title	Categories	Date updated	Version	Units	File Type	Link	doc_categories_hfilter	doc_tags_hfilter
	Industry Communication on Interim Measures Pending Update of Variation Addendum	Communication to industry, Guideline	2020 Sep	1	General ECTD & human medicines	pdf	Download	communication-to-industry guideline	general-ectd-human-medicines-guidelines
9.125	BAU variations communication	Communication to industry, Guideline	2022 Feb	3	General ECTD & human medicines	pdf	Download	communication-to-industry guideline	general-ectd-human-medicines-guidelines
	SAHPRA INVOLVEMENT IN THE SWISSMEDIC MARKETING AUTHORISATION FOR GLOBAL HEALTH PRODUCTS (MAGHP) PROCEDURE	Communication to industry	2021 Nov	1	General ECTD & human medicines	pdf	Download	communication-to-industry	general-ectd-human-medicines-guidelines
2.17	Communication to industry on the sartans-containing medicines	Communication to industry	2020 Oct	2	General ECTD & human medicines	pdf	Download	communication-to-industry	general-ectd-human-medicines-guidelines
2.18	Communication to industry on ranitidine-containing medicines	Communication to industry	2020 Oct	1	General ECTD & human medicines	pdf	Download	communication-to-industry	general-ectd-human-medicines-guidelines
2.19	Communication to industry on metformin-containing medicines	Communication to industry	2020 Oct	1	General ECTD & human medicines	pdf	Download	communication-to-industry	general-ectd-human-medicines-guidelines
	Communication to industry on Clones and Replicas	Communication to industry	2020 Nov	1	General ECTD & human medicines	pdf	Download	communication-to-industry	general-ectd-human-medicines-guidelines
9.132	Priority Review Requests Communication	Communication to industry, Guideline	2022 Feb	1	General ECTD & human medicines	pdf	Download	communication-to-industry guideline	general-ectd-human-medicines-guidelines
	Payment of annual retention fees for registered products	Communication to industry	2022 May	1	General ECTD & human medicines	pdf	Download	communication-to-industry	general-ectd-human-medicines-guidelines
	Retention Fee Notification – 9 June 2022	Communication to industry	June 2022	1	Biological Medicines Evaluation and Research, General ECTD & human medicines, Inspectorate and good manufacturing practices, Medical Devices	pdf	Download	communication-to-industry	biological-medicines-evaluation-and-research general-ectd-human-medicines-guidelines inspectorate-and-good-manufacturing-practices medical-devices
	Communication on Medicines Registration Renewals Implementation Framework	Communication to industry, Guideline	June 2022	1	Biological Medicines Evaluation and Research, General ECTD & human medicines, Quality, Veterinary medicines	pdf	Download	communication-to-industry guideline	biological-medicines-evaluation-and-research general-ectd-human-medicines-guidelines quality veterinary-medicines
	Communication to Industry on Nitrosamine Review for New Applications and Registered Products including Biologicals	Communication to industry	June 2022	1	General ECTD & human medicines	pdf	Download	communication-to-industry	general-ectd-human-medicines-guidelines